Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Research Article

Del-1 in Psoriasis Induced the Expression of αvβ3 and α5β1 in Endothelial Cells

Author(s): Xuping Niu, Qixin Han, Xiaofang Li, Juan Li, Yanmin Liu, Yan Li and Yan Wu*

Volume 22, Issue 5, 2022

Published on: 20 August, 2021

Page: [442 - 448] Pages: 7

DOI: 10.2174/1566524021666210729112700

Price: $65

conference banner
Abstract

Objective: Psoriasis is a chronic inflammatory skin disease highly depending on angiogenesis. Our prior results showed that the mRNA and protein of Del-1 in dermal mesenchymal stem cells (dMSCs) was up-regulated from psoriasis. Our aim was further to investigate the role of Del-1 from dMSCs in the pathogenesis of psoriasis and confirm the effect of Del-1 on the pathogenesis of psoriasis.

Methods: We conducted an immunohistochemistry experiment to further investigate the expression of Del-1in psoriatic lesions. In addition, dMSCs with over-expressed Del-1 via the lentiviral vector of Del-1 were co-cultured with ECs, and the protein expression of integrins (αvβ3, αvβ5 ,and α5β1) of ECs were detected by western blotting.

Results: This research showed that Del-1 was significantly increased in lesions of patients with psoriasis (p< .05, 9.96 vs. 2.18), and Del-1 from dMSCs successfully induced up-regulation of integrins α5β1 and αvβ3 (all p < .05).

Conclusion: This study demonstrated that Del-1 from dMSCs was involved in the pathogenesis of psoriasis through induced angiogenesis. And Del-1, αvβ3 and α5β1 may be potential new targets for inhibiting angiogenesis in psoriasis.

Keywords: Psoriasis, Del-1, dermal mesenchymal stem cells (dMSCs), integrin, angiogénesis, western blotting.

« Previous Next »
[1]
Ho HK, Jang JJ, Kaji S, et al. Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: Its role in ischemia. Circulation 2004; 109(10): 1314-9.
[http://dx.doi.org/10.1161/01.CIR.0000118465.36018.2D] [PMID: 14981004]
[2]
Shin J, Hosur KB, Pyaram K, et al. Expression and function of the homeostatic molecule Del-1 in endothelial cells and the periodontal tissue. Clin Dev Immunol 2013; 2013617809
[http://dx.doi.org/10.1155/2013/617809] [PMID: 24416060]
[3]
Wang Z, Boyko T, Tran MC, et al. DEL1 protects against chondrocyte apoptosis through integrin binding. J Surg Res 2018; 231: 1-9.
[http://dx.doi.org/10.1016/j.jss.2018.04.066] [PMID: 30278915]
[4]
Penta K, Varner JA, Liaw L, Hidai C, Schatzman R, Quertermous T. Del1 induces integrin signaling and angiogenesis by ligation of alphaVbeta3. J Biol Chem 1999; 274(16): 11101-9.
[http://dx.doi.org/10.1074/jbc.274.16.11101] [PMID: 10196194]
[5]
Ciucurel EC, Sefton MV. Del-1 overexpression in endothelial cells increases vascular density in tissue-engineered implants containing endothelial cells and adipose-derived mesenchymal stromal cells. Tissue Eng Part A 2014; 20(7-8): 1235-52.
[http://dx.doi.org/10.1089/ten.tea.2013.0242] [PMID: 24151812]
[6]
Hidai C, Zupancic T, Penta K, et al. Cloning and characterization of developmental endothelial locus-1: An embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev 1998; 12(1): 21-33.
[http://dx.doi.org/10.1101/gad.12.1.21] [PMID: 9420328]
[7]
Takada Y, Ye X, Simon S. The integrins. Genome Biol 2007; 8(5): 215.
[http://dx.doi.org/10.1186/gb-2007-8-5-215] [PMID: 17543136]
[8]
Rocha LA, Learmonth DA, Sousa RA, Salgado AJ. αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine? Biotechnol Adv 2018; 36(1): 208-27.
[http://dx.doi.org/10.1016/j.biotechadv.2017.11.004] [PMID: 29155160]
[9]
Boudreau NJ, Varner JA. The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis. J Biol Chem 2004; 279(6): 4862-8.
[http://dx.doi.org/10.1074/jbc.M305190200] [PMID: 14610084]
[10]
McFadden J, Fry L, Powles AV, Kimber I. Concepts in psoriasis: Psoriasis and the extracellular matrix. Br J Dermatol 2012; 167(5): 980-6.
[http://dx.doi.org/10.1111/j.1365-2133.2012.11149.x] [PMID: 22803790]
[11]
Zhong J, Eliceiri B, Stupack D, et al. Neovascularization of ischemic tissues by gene delivery of the extracellular matrix protein Del-1. J Clin Invest 2003; 112(1): 30-41.
[http://dx.doi.org/10.1172/JCI17034] [PMID: 12840057]
[12]
Nickoloff BJ. Characterization of lymphocyte-dependent angiogenesis using a SCID mouse: Human skin model of psoriasis. J Investig Dermatol Symp Proc 2000; 5(1): 67-73.
[http://dx.doi.org/10.1046/j.1087-0024.2000.00006.x] [PMID: 11147678]
[13]
Fan Y, Zhu W, Yang M, et al. Del-1 gene transfer induces cerebral angiogenesis in mice. Brain Res 2008; 1219: 1-7.
[http://dx.doi.org/10.1016/j.brainres.2008.05.003] [PMID: 18534562]
[14]
Jeong D, Ban S, Oh S, Jin Lee S, Yong Park S, Koh YW. Prognostic significance of edil3 expression and correlation with mesenchymal phenotype and microvessel density in lung adenocarcinoma. Sci Rep 2017; 7(1): 8649.
[http://dx.doi.org/10.1038/s41598-017-08851-9] [PMID: 28819306]
[15]
Niu X, Chang W, Liu R, et al. mRNA and protein expression of the angiogenesis-related genes EDIL3, AMOT and ECM1 in mesenchymal stem cells in psoriatic dermis. Clin Exp Dermatol 2016; 41(5): 533-40.
[http://dx.doi.org/10.1111/ced.12783] [PMID: 26644074]
[16]
Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis 2002; 5(4): 231-6.
[http://dx.doi.org/10.1023/A:1024515517623] [PMID: 12906316]
[17]
Teoh CM, Tan SSL, Tran T. Integrins as therapeutic targets for respiratory diseases. Curr Mol Med 2015; 15(8): 714-34.
[http://dx.doi.org/10.2174/1566524015666150921105339] [PMID: 26391549]
[18]
Matsushita J, Inagaki S, Nishie T, et al. Fluorescence and bioluminescence imaging of angiogenesis in flk1-nano-lantern transgenic mice. Sci Rep 2017; 7: 46597.
[http://dx.doi.org/10.1038/srep46597] [PMID: 28425492]
[19]
Hou R, Yin G, An P, et al. DNA methylation of dermal MSCs in psoriasis: Identification of epigenetically dysregulated genes. J Dermatol Sci 2013; 72(2): 103-9.
[http://dx.doi.org/10.1016/j.jdermsci.2013.07.002] [PMID: 23916410]
[20]
Ryu YH, Lee YJ, Kim KJ, Lee SJ, Han YN, Rhie JW. Epidermal growth factor (egf)-like repeats and discoidin i-like domains 3 (EDIL3): A potential new therapeutic tool for the treatment of keloid scars. Tissue Eng Regen Med 2017; 14(3): 267-77.
[http://dx.doi.org/10.1007/s13770-017-0034-5] [PMID: 30603483]
[21]
Zou X, Qiao H, Jiang X, Dong X, Jiang H, Sun X. Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer. J Biomed Sci 2009; 16: 33.
[http://dx.doi.org/10.1186/1423-0127-16-33] [PMID: 19292890]
[22]
Klotzsche-von Ameln A, Cremer S, Hoffmann J, et al. Endogenous developmental endothelial locus-1 limits ischaemia-related angiogenesis by blocking inflammation. Thromb Haemost 2017; 117(6): 1150-63.
[http://dx.doi.org/10.1160/TH16-05-0354] [PMID: 28447099]
[23]
Orciani M, Campanati A, Salvolini E, et al. The mesenchymal stem cell profile in psoriasis. Br J Dermatol 2011; 165(3): 585-92.
[http://dx.doi.org/10.1111/j.1365-2133.2011.10438.x] [PMID: 21623755]
[24]
Creamer D, Allen M, Sousa A, Poston R, Barker J. Altered vascular endothelium integrin expression in psoriasis. Am J Pathol 1995; 147(6): 1661-7.
[PMID: 7495291]
[25]
Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol 2017; 76(3): 377-90.
[http://dx.doi.org/10.1016/j.jaad.2016.07.064] [PMID: 28212759]

Rights & Permissions Print Cite
Article Metrics
23
1
© 2024 Bentham Science Publishers | Privacy Policy